Suchergebnisse - "Nicholas, Jacqueline"

PubPharm (7)

1

Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumab

enthalten in: Multiple sclerosis and related disorders | 2022

von Nicholas, J. | Gudesblatt, M. | Garabedian, M. | +6

2

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

enthalten in: BMC neurology | 2020

von Nicholas, J. | Edwards, N. | Edwards, R. | +3

3

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

enthalten in: BMC neurology | 2020

von Nicholas, J. | Edwards, N. | Edwards, R. | +3

4

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis : a systematic review and meta-analysis

enthalten in: BMC neurology | 2020

von Nicholas, J. | Edwards, N. | Edwards, R. | +3

5

Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US

enthalten in: Multiple sclerosis and related disorders | 2019

von Ontaneda, D. | Nicholas, J. | Carraro, M. | +7

6

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis : Analysis of a Large Health Insurance Claims Database

enthalten in: Neurology and therapy | 2017

von Boster, A. | Nicholas, J. | Wu, N. | +5

7

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

enthalten in: Neurology and Therapy | 2017

von Boster, A. | Nicholas, J. | Wu, N. | +5

1
[1]